Estimation of genetic risk for Type 1 diabetes mellitus in newborns on dried blood spot.

Journal of Endocrinological Investigation
A GiannattasioG d'Annunzio

Abstract

The main contribution to genetic susceptibility for Type 1 Diabetes Mellitus (T1DM) is conferred by the Human Leukocyte Antigens (HLA). We evaluated the feasibility of large scale screening on Dried Blood Spot (DBS) to estimate the genetic risk for T1DM in newborns. Peripheral blood DBS samples from 256 newborns, were genotyped for HLA DRB1 and DQB1 alleles identification by a commercially available assay based on a dissociation enhancer lanthanide fluorescence system available in many newborn screening laboratories. Results were compared with those obtained in two wide multicentric studies on cord blood (DIABFIN and PREVEFIN). Genotyping on DBS revealed 6 subjects at high risk for T1DM, 99 at moderate risk for T1DM and the remaining at low risk for T1DM. We found 100% concordance between both techniques for HLA-DQB1 and DRB1 determination, confirming the feasibility of large scale screening on DBS. DBSs represent a resource for future studies about new genetics markers. This assay for estimate the genetic risk of T1DM on DBS showed an excellent sensitivity, specificity and accuracy compared with conventional techniques. Moreover, this assay resulted less expensive, and it could be easily performed on material already collected...Continue Reading

References

Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A Todd
Nov 24, 1994·The New England Journal of Medicine·M A Atkinson, N K Maclaren
Nov 29, 2001·Diabetologia·A GreenUNKNOWN EURODIAB TIGER Study Group. Europe and Diabetes
Feb 20, 2003·The Journal of Allergy and Clinical Immunology·Devasenan Devendra, George S Eisenbarth
May 14, 2004·The New England Journal of Medicine·George S Eisenbarth, Peter A Gottlieb
Mar 15, 2006·Lancet·Denis Daneman
Aug 31, 2006·Diabetes Technology & Therapeutics·Paul DantonioW Harry Hannon

❮ Previous
Next ❯

Citations

Aug 13, 2013·Journal of Empirical Research on Human Research Ethics : JERHRE·Elicia D Preslan, Debra J H Mathews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.